- Home
- EMCG vs DTIL Comparison
EMCG vs DTIL Comparison
Compare EMCG & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMCG
- DTIL
- Stock Information
- Founded
- EMCG 2021
- DTIL 2006
- Country
- EMCG United States
- DTIL United States
- Employees
- EMCG N/A
- DTIL N/A
- Industry
- EMCG
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- EMCG
- DTIL Health Care
- Exchange
- EMCG NYSE
- DTIL Nasdaq
- Market Cap
- EMCG 52.4M
- DTIL 44.1M
- IPO Year
- EMCG 2022
- DTIL 2019
- Fundamental
- Price
- EMCG $11.68
- DTIL $4.75
- Analyst Decision
- EMCG
- DTIL Strong Buy
- Analyst Count
- EMCG 0
- DTIL 2
- Target Price
- EMCG N/A
- DTIL $39.50
- AVG Volume (30 Days)
- EMCG 2.6K
- DTIL 192.8K
- Earning Date
- EMCG 01-01-0001
- DTIL 11-04-2024
- Dividend Yield
- EMCG N/A
- DTIL N/A
- EPS Growth
- EMCG N/A
- DTIL N/A
- EPS
- EMCG 0.23
- DTIL 1.45
- Revenue
- EMCG N/A
- DTIL $75,096,000.00
- Revenue This Year
- EMCG N/A
- DTIL $50.33
- Revenue Next Year
- EMCG N/A
- DTIL N/A
- P/E Ratio
- EMCG $49.99
- DTIL $2.46
- Revenue Growth
- EMCG N/A
- DTIL 43.62
- 52 Week Low
- EMCG $10.96
- DTIL $3.61
- 52 Week High
- EMCG $13.39
- DTIL $19.43
- Technical
- Relative Strength Index (RSI)
- EMCG 59.70
- DTIL 41.95
- Support Level
- EMCG $11.63
- DTIL $3.61
- Resistance Level
- EMCG $11.74
- DTIL $5.00
- Average True Range (ATR)
- EMCG 0.02
- DTIL 0.52
- MACD
- EMCG 0.00
- DTIL 0.08
- Stochastic Oscillator
- EMCG 33.33
- DTIL 44.44
About EMCG EMBRACE CHANGE ACQUISITION CORP
Embrace Change Acquisition Corp is a blank check company. It is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.